Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
48,347,939
-
Share change
-
-10,579,050
-
Total reported value
-
$22,700,996
-
Put/Call ratio
-
12%
-
Price per share
-
$0.47
-
Number of holders
-
116
-
Value change
-
-$5,968,243
-
Number of buys
-
24
-
Number of sells
-
41
Institutional Holders of AMPIO PHARMACEUTICALS INC - COM (AMPE) as of Q1 2022
As of 31 Mar 2022,
AMPIO PHARMACEUTICALS INC - COM (AMPE) was held by
116 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
48,347,939 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, Willis Investment Counsel, NORTHERN TRUST CORP, CVA Family Office, LLC, Western Wealth Management, LLC, and PRIVATE CAPITAL MANAGEMENT LLC.
This page lists
116
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.